Song, Yipei
Cisternino, Francesco
Mekke, Joost M.
de Borst, Gert J.
de Kleijn, Dominique P. V.
Pasterkamp, Gerard
Vink, Aryan
Glastonbury, Craig A.
van der Laan, Sander W.
Miller, Clint L.
Funding for this research was provided by:
Fondation Leducq (18CVD02, 18CVD02)
Horizon 2020 (TO_AITION 848146)
National Institutes of Health (R00HL125912)
Article History
Received: 6 September 2022
Accepted: 8 February 2023
First Online: 15 March 2023
Competing interests
: Dr. Sander W. van der Laan has received Roche funding for unrelated work. Dr Craig A. Glastonbury has stock options in BenevolentAI and is a paid consultant for BenevolentAI, unrelated to this work. Dr. Clint L. Miller has received AstraZeneca funding for unrelated work. All other authors declare that they have no competing interests relevant to the contents of this paper to disclose.